In/IN this/DT study/NN ,/, we/PRP executed/VBD a/DT genomic/JJ analysis/NN with/IN the/DT objective/NN of/IN selecting/VBG a/DT set/NN of/IN genes/NNS (/-LRB- possibly/RB small/JJ )/-RRB- that/WDT would/MD help/VB in/IN the/DT detection/NN and/CC classification/NN of/IN samples/NNS from/IN patients/NNS affected/VBN by/IN Parkinson/NNP Disease/NNP ./.
We/PRP performed/VBD a/DT complete/JJ data/NNS analysis/NN and/CC during/IN the/DT exploratory/JJ phase/NN ,/, we/PRP selected/VBD a/DT list/NN of/IN differentially/RB expressed/VBN genes/NNS ./.
Despite/IN their/PRP$ association/NN with/IN the/DT diseased/JJ state/NN ,/, we/PRP could/MD not/RB use/VB them/PRP as/IN a/DT biomarker/NN tool/NN ./.
Therefore/RB ,/, our/PRP$ research/NN was/VBD extended/VBN to/TO include/VB a/DT multivariate/JJ analysis/NN approach/NN resulting/VBG in/IN the/DT identification/NN and/CC selection/NN of/IN a/DT group/NN of/IN 20/CD genes/NNS that/WDT showed/VBD a/DT clear/JJ potential/NN in/IN detecting/VBG and/CC correctly/RB classify/VB Parkinson/NNP Disease/NNP samples/NNS even/RB in/IN the/DT presence/NN of/IN other/JJ neurodegenerative/JJ disorders/NNS ./.
